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Edited by Maurice MontalAbstract The tandem aﬃnity puriﬁcation (TAP) procedure was
initially developed as a tool for rapid puriﬁcation of native
protein complexes expressed at their natural levels in yeast cells.
This puriﬁcation procedure was also applied to study interactions
between soluble proteins in mammalian cells. In order to apply
this procedure to mammalian membrane proteins, we created a
modiﬁed TAP tag expression vector and fused with the PKD2
gene, encoding a membrane cation channel protein, polycystin-2,
mutated in 15% of autosomal dominant polycystic kidney
disease. We generated epithelial Madin–Darby canine kidney
cell line stably expressing TAP-tagged polycystin-2, improved
the subsequent steps for membrane protein release and stability,
and succeeded in purifying this protein. Using patch clamp
electrophysiology, we detected speciﬁc polycystin-2 channel
activities when the puriﬁed protein was reconstituted into a lipid
bilayer system. Thus, this modiﬁed TAP procedure provides a
powerful alternative to functionally characterize membrane
proteins, such as ion channels, transporters and receptors, using
cell-free system derived from mammalian cells.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Classical biochemical puriﬁcation methods rely heavily on
the biological properties of a given protein, such as size, shape,
charge, hydrophobicity and solubility, and are generally time-,
labor- and cost-consuming. More importantly, as each protein
is unique, puriﬁcation protocols for individual proteins are
often designed on an empirical basis [1]. The complexity of the
mammalian genome and lack of a generic protein puriﬁcation
protocol hamper the progress in elucidating protein functions.
Thus, there is critical demand for developing widely applicable* Corresponding author. Fax: +1-780-492-8915.
E-mail address: xzchen@ualberta.ca (X.-Z. Chen).
Abbreviations: TAP, tandem aﬃnity puriﬁcation; MDCK, Madin–
Darby canine kidney; IgG, immunoglobulin; CBP, calmodulin-binding
peptide; TEV, tobacco etch virus; CMV, cytomegalovirus; TBS, Tris-
buﬀered saline
0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.09.017and eﬃcient puriﬁcation procedures for isolating proteins from
mammalian cells.
Among a variety of protein puriﬁcation techniques, epitope-
tagged aﬃnity puriﬁcation appears to be the most powerful
and a gentle discriminatory separation technique for protein
retrieval. In particular, well-characterized small aﬃnity tags
such as FLAG, hexahistidine, hemagglutinin, maltose and
glutathione S-transferase have been extensively utilized in af-
ﬁnity puriﬁcation of recombinant proteins. In the last decade,
a tandem aﬃnity puriﬁcation (TAP) method was developed
[2,3], which utilized two consecutive aﬃnity puriﬁcation steps
[3]. Nowadays, there are many aﬃnity puriﬁcation tags avail-
able, several of which have low aﬃnity for their cognate li-
gands such that low protein yield is obtained [1]. Rigaut et al.
[2] compared several tag combinations aiming at high recovery
rates without aﬀecting protein functions and developed what
has later become a standard TAP tag. This TAP tag consists of
two immunoglobulin (IgG)-binding domains of Staphylococ-
cus aureus, protein A and a calmodulin-binding peptide (CBP),
separated by a cleavage site for the tobacco etch virus (TEV)
protease. The TAP-tagged protein is expressed in host cells at
close to physiological concentrations to form a complex with
endogenous components. Extracts prepared from cells ex-
pressing TAP-tagged proteins are subjected to two successive
puriﬁcation steps. The ﬁrst step involves binding of the protein
A tag to an IgG column and eluting bound materials by in-
cubation with TEV protease. This elution step signiﬁcantly
reduces the contaminating proteins bound non-speciﬁcally to
the column. The eluates that contain the target proteins are
subjected to the second-step puriﬁcation, consisting of incu-
bation with calmodulin-coated beads to remove TEV protease
and contaminants. Highly puriﬁed target proteins are eluted by
removing free calcium ions using calcium chelator EGTA.
Therefore, these two steps of aﬃnity puriﬁcation can produce
highly pure protein of interest together with associated part-
ners under standard conditions [2–5].
This TAP approach was more recently introduced by some
researchers into various types of host cells, such as bacteria,
Drosophila, plant and mammalian cells and used to identify
novel protein–protein interactions [6–12]. In this report, we
attempted to purify a membrane-associated channel protein,
polycystin-2, for in vitro electrophysiological studies. Due to
low abundance of endogenous polycystin-2 protein in many
cells, it is uneasy to study its biophysical properties and in-
teraction with protein partners. Heterologous expression ofation of European Biochemical Societies.
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abundance. However, overexpressed polycystin-2 targets
mostly to membranes of intracellular organelles such as that of
endoplasmic reticulum [13,14], which makes it diﬃcult for
electrophysiological studies. Currently, most of polycystin-2
channel studies use in vitro translated proteins or puriﬁed
proteins from insect cells [15–17]. Here, we performed two
consecutive aﬃnity puriﬁcations of the polycystin-2 protein
from cultured mammalian cells. To develop a generic protein
puriﬁcation protocol that is applicable to the identiﬁcation of
membrane proteins in mammalian cells, we incorporated a
TAP tag to the N-terminus of human polycystin-2. We stably
expressed polycystin-2 in mammalian cells at desirable levels
by liposome-based gene transfer and puriﬁed the protein from
total cell lysates. The combination of two diﬀerent high-aﬃnity
tags greatly reduced the number of non-speciﬁc proteins in the
mixture. We demonstrated the presence of polycystin-2 protein
in a ﬁnal elution buﬀer by Western blotting, which validates
our modiﬁed TAP puriﬁcation approach. We reconstituted
puriﬁed polycystin-2 into planar lipid bilayer to determine
whether it exhibits channel function. Indeed, speciﬁc cation
channel activities were observed using a lipid bilayer patch
clamp system. The modiﬁed TAP approach should also apply
to other proteins and provide an eﬃcient way to purify them to
homogeneity from complex mixture found in mammalian cell
lysates.2. Materials and methods
2.1. Plasmid construction
The N-terminal TAP-tagged polycystin-2 was constructed in three
steps based on the vector pEGFPC2 (Clontech, Palo Alto, CA). First,
the TAP tag was ampliﬁed from the plasmid pBS1761 (courtesy gift
from Dr. R.M. Zhao, University of Toronto, Canada) with a pair of
primers (50-CTGCAGGCTAGCACCGGTATGGCAGGCCTTGCG
CAACA-30 and 50-AAGCTTGAGCTCGAGATCAG CTTATCGT-
CATCATCAAG-3) and subcloned into the vector pGEM-Teasy
(Promega, Madison, MI). Second, the resulting fragment was used to
substitute the EGFP sequence located between AgeI and HindIII in
pEGFPC2 to generate pTAPC2 vector. Finally, the entire open reading
frame of the human PKD2 gene was inserted into the XhoI–KpnI site of
pTAPC2 to generate pTAPC2-PKD2. The plasmid construct was
conﬁrmed by sequencing.2.2. Transfection and selection of stable cell line
Mouse ﬁbroblast NIH 3T3 and Madin–Darby canine kidney
(MDCK) type II cells were maintained in Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM) supplemented with L-glutamine, penicillin-
streptomycin, and 10% fetal bovine serum. Cells were plated onto a
6-well cluster and cultured to 90% conﬂuence. Transfection was
performed using Lipofectamine 2000 (Invitrogen, Toronto, ON)
according to the manufacturer’s recommendation. For generation of
pooled stable cell line, 800 lg/ll hygromycin (Invitrogen) was added
to DMEM to select viable clones one (recovery) day following
transfection. The selection process was maintained for eight weeks
with daily medium change.
2.3. Puriﬁcation of TAP-tagged polycystin-2 protein
In order to eﬃciently release polycystin-2 membrane proteins from
cultured cells, four diﬀerent lysis buﬀers were tried and compared be-
fore making batch puriﬁcation. They include two mild lysis buﬀers
with non-ionic detergent NP40 (50 mM Tris, pH 8.0, 150 mM NaCl,
and 1% Nonidet P40) and Triton X-100 (50 mM Tris, pH 8.0, 150 mM
NaCl, and 1% Triton X-100), one strong RIPA lysis buﬀer (50 mM
Tris, pH 8.0, 150 mM NaCl, 1% Nonidet P40, 0.5% sodium deoxy-
cholate, and 0.1% SDS) and the commercial CellLytic-M reagent
(Cat #: C2978, Sigma–Aldrich Canada, Oakville, ON).All the following puriﬁcation steps were conducted at 4 C.
MDCK monolayers grown at 150 mm dishes were lysed in 1.2 ml of
ice-cold Sigma CellLytic-M reagent supplemented with protease
inhibitor cocktail (Sigma–Aldrich Canada) and then scraped oﬀ. The
resulting homogenate was cleared by centrifugation at 15 000· g for
20 min. Batch puriﬁcation of the IgG binding domain-tagged pro-
tein was performed using 300 ll (5 dishes) of protein A Sepharose 4
Fast Flow resin (Sigma–Aldrich Canada). Lysates were incubated
with the resin overnight, washed three times with 10 ml of Tris-
buﬀered saline (TBS) plus 0.1% Tween 20, and then three times with
10 ml of TEV buﬀer (50 mM Tris, pH 8.0, 1 mM EDTA). The
beads were cut oﬀ from the tagged proteins using 300 units (500 ll)
of TEV protease (Invitrogen) overnight. Supernatants from the TEV
reaction containing the cleaved TAP tagged polycystin-2 were col-
lected. The beads were washed twice with a 2 ml calmodulin binding
buﬀer (50 mM Tris, pH 8.0, 75 mM NaCl, and 2 mM CaCl2). The
supernatants were combined and batch-puriﬁed by binding 200 ll of
calmodulin aﬃnity gel resin (Sigma–Aldrich Canada) for 4 h, wa-
shed ﬁve times with 5 ml of TBS, and eluted with a calmodulin
elution buﬀer (50 mM Tris, pH 8.0, 25 mM EGTA). To validate
drug-resistant colonies and fusion protein production, immunoﬂuo-
rescent staining and Western blotting were conducted as described
previously [14] and silver staining was performed as per the manu-
facturer’s protocol (Bio-Rad, Mississauga, ON).
2.4. Preparations of planar lipid bilayer and proteoliposome containing
polycystin-2
The methods of preparation were based on those described pre-
viously [15,17]. Brieﬂy, planar lipid bilayers were formed with a
mixture of synthetic phospholipids (Avanti Polar Lipids, Birming-
ham, AL) in n-decane. The lipid mixture (25 mg/ml) was composed
of phosphatidylethanolamine and phosphatidylserine in a 7:3 ratio.
To prepare proteoliposome containing polycystin-2, the protein was
dialyzed with phospholipids for lipid bilayer membrane assays. In
brief, the same lipid mixture as above was sonicated with a solution
containing 150 mM NaCl, 0.1 mM EDTA, 25 mM Naþ-cholate and
20 mM HEPES, pH 7.2. Polycystin-2 was added to a Naþ-cholate
(0.55 mM) solution and the phospholipid mixture (25 mg/ml). The
mixture was dialyzed for three days in 150 mM NaCl, 0.1 mM
EDTA, and 20 mM HEPES, pH 7.2, with daily buﬀer change to
eliminate residual detergent.2.5. Electrophysiological measurements
Lipid membrane was formed across a 0.2 mm hole in a Delrin cup
inserted in a special acrylic chamber (Harvard Apparatus, Montreal,
QC) by painting with a glass stick containing either the lipid mixture or
proteoliposome. Two solution-ﬁlled compartments were formed and
separated by the membrane and are designated cis (or intracellular) and
trans (or extracellular). The cis compartment contained 150 mM KCl,
15 lM Ca2þ (by 1 mM EGTA and 1.01 mM CaCl2), pH 7.4 (adjusted
by MOPS-KOH). The trans chamber contained either the identical
solution as in cis (to form a symmetrical condition) or 15 mM KCl
(asymmetrical). Polycystin-2 protein was added to the cis chamber in
proximity of the membrane formed by the lipid mixture. Alternatively,
polycystin-2-containing proteoliposome was directly painted to form
the membrane with proteins expectedly inserted. The cis compartment
was clamped to a range of voltages using a Gapfree protocol generated
by Clampex 8 (Axon Instruments, Union City, CA) and the trans
compartment was held at ground (0 mV). Currents and voltages were
recorded at 200 ls per sample, Bessel ﬁltered at 1K or 3K Hz with the
ampliﬁer PC-ONE (Dagan Corporation, Minneapolis, MN), the AD/
DA converter Digidata 1320A and the software Clampex 8 (Axon
Instruments).
2.6. Statistics and data analysis
Data were analyzed using Clampﬁt 9.2 (Axon Instruments). Sin-
gle-channel current amplitudes were obtained from Gaussian ﬁts to
All-Point Histograms. For the analysis of mean open time (MOT)
and mean close time (MCT), recordings with single openings ﬁltered
(Gaussian) at 200 Hz were used. Analyzed data were ﬁtted and
plotted using Sigmaplot 8 (Jandel Scientiﬁc, San Rafael, CA) and
expressed in the form of meansS.E. (N ). The Goldman–Hodgkin–
Katz (GHK) current equation [18] was used to evaluate the main
unitary conductance.
Fig. 1. Mammalian expression plasmid pTAPC2-PKD2 construct. (A)
Schematic diagram of the plasmid pTAPC2-PKD2. (B) Structure and
sequence of the N-terminal tandem tags. The TAP tag consists of two
tandem protein A IgG binding domains (58 a.a. each), a TEV cleavage
sequence (7 a.a., cleavage site between Q and G), and calmodulin
binding peptide sequence (26 a.a). There is also an entrokinase rec-
ognition site (5 a.a.) [2]. They were placed downstream of CMV pro-
moter, followed by the in-frame human PKD2 gene, and terminated
with SV40 polyadenylation (pA) signal. Neo/Kan, neomycin or
kanamycin resistance gene with SV40 promoter and herpes simplex
virus (HSV) thymidine kinase (TK) polyadenylation signal. Ori, origin
of replication.
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3.1. Generation of stable mammalian cell line expressing
TAP-tagged polycystin-2
The TAP method has been proven to be a powerful generic
protein puriﬁcation method for functional proteomics studies
in various host cells. To develop a comparable methodology
for protein puriﬁcation from cultured mammalian cells, we
constructed a TAP vector based on the mammalian expression
vector pEGFPC2 (Clontech). As shown in Fig. 1, the TAP
cassette contains two copies of the IgG binding domain of
protein A of S. aureus and a CBP with a cleavage site for TEV
protease. Both aﬃnity tags have been selected for high eﬃcient
recovery of proteins present at low concentrations. Protein A
binds tightly to an IgG matrix, which requires the use of TEV
protease to elute materials under native conditions. The eluate
was then incubated with calmodulin-coated beads for further
puriﬁcation. There is also an entrokinase recognition site
which allows to remove the whole TAP tag if necessary. The
full-length human PKD2 gene was inserted in-frame into
downstream of the TAP sequence. The total gene cassette was
placed under the control of the cytomegalovirus (CMV) pro-
moter to drive its constitutive expression. There is a Neo gene
for G418 drug resistance marker for selection in mammalian
cells.
To assess whether these tandem aﬃnity tags are in a
correct fusion format and suitable for mammalian cell ex-
pression, we transiently transfected pTAPC2-PKD2 into two
extensively studied cell lines, mouse ﬁbroblast NIH 3T3 andcanine epithelial MDCK cells. Indeed, a speciﬁc band of
about 140 kDa was visualized by Western blotting probed
with the anti-polycystin-2 [14] or anti-rabbit IgG antibody
(Fig. 2A) from the total lysates of both cell lines. Immu-
noﬂuorescent staining showed complete image overlaps with
the same pair of antibodies (Fig. 2B), indicative of the
feasibility of this puriﬁcation strategy in mammalian cells.
Subsequently, we chose MDCK cells for generation of a
stable cell line for two reasons. First, MDCK cells are de-
rived from kidney with high growing speeds, which allows us
to collect large quantities of cell lysates. Second, MDCK
cells are able to form a tight epithelium to tolerate high
selection pressure over a long period of time and to eﬃ-
ciently express exogenous proteins. To relieve ourselves from
the work such as drug-resistant colony pickup and individ-
ual characterization and to reduce the cost, we performed
eight-week selection in a 6-well cluster with daily medium
change. The surviving colonies in the cluster exhibited var-
ious expression levels of the TAP-tagged polycystin-2 protein
(Fig. 2C). This pool of cells stably expressing TAP-polycy-
stin-2 was used for subsequent protein retrieval and puriﬁ-
cation. The same strategy was also successfully applied to
puriﬁcation of polycystin-L, a homologous (50% identical)
membrane protein of polycystin-2 (data not shown), sug-
gesting its applicability to other proteins.3.2. Puriﬁcation of polycystin-2 protein
Polycystin-2 is a membrane protein and associates with the
actin cytoskeleton [14,19,20]. We attempted to search for the
most suitable lysis buﬀer which can release membrane protein
eﬃciently without disrupting its structural integrity. Four
diﬀerent lysis buﬀers were compared. Two commonly used
mild lysis buﬀers with non-ionic detergent NP40 or Triton X-
100, one strong RIPA lysis buﬀer with ionic and non-ionic
detergent, and one commercial lysis buﬀer CellLytic from
Sigma were compared. Obviously, the RIPA or CellLytic
buﬀers gave more complete protein release from MDCK cells
than NP40 or Triton X-100 buﬀers, as judged by signal in-
tensity of Western blotting in the pellet after protein extraction
(Fig. 3). Between RIPA and CellLytic, it is clear that the latter
produced higher amounts of soluble protein present in the
supernatant, perhaps due to its stabilization eﬀect on proteins.
Therefore, the CellLytic buﬀer was used in our subsequent
protein release.
Protein extracts were prepared from MDCK cells and incu-
bated with IgG-sepharose 4 Fast Flow beads. The IgG beads
were recovered as described above and a portion of the eluates
was analyzed on a SDS–PAGE gel. As shown in Fig. 4, IgG
beads signiﬁcantly enriched the TAP-tagged polycystin-2 pro-
tein, when compared with the unfractionated cell lystates (lane 1
vs. lane 2). Eluates obtained after TEV cleavage were further
incubated with calmodulin beads. After washing the beads ﬁve
timeswith theTBSbuﬀer, proteins bound to theCBPbeadswere
eluted in the presence of EGTA (25 mM). The second-step pu-
riﬁcation with the CBP further increased purity of the tagged
polycystin-2 protein. A single 120 kDa protein band was visu-
alized by Western blotting probed with the anti-polycystin-2
antibody in the eluates from TEV removal and CBP beads
(Fig. 4). This smaller band is due to the removal of two IgG
binding domains from the TAP-tagged polycystin-2. Thus,
polycystin-2 protein was successfully puriﬁed from cultured
Fig. 3. Release of polycystin-2 protein from MDCK cells using diﬀerent detergents. Four diﬀerent lysis buﬀers, CellLytic, RIPA, NP40 and Triton,
containing one or more detergents were used for protein extraction. Precleared supernatant and its respective pellet (150 lg each) from total cell
lysates were run on 8% SDS–PAGE and blotted with the anti-polycystin-2 antibody. Molecular mass (in kDa) is indicated.
Fig. 2. TAP-tagged polycystin-2 overexpressed in NIH 3T3 and MDCK cells. (A) Western blot analysis of TAP-tagged polycystin-2 expression in
transiently transfected NIH 3T3 and MDCK cells and their controls. Total cell lysates were subjected to 8% SDS–PAGE, transferred to nitrocel-
lulose membrane, and blotted with the anti-polycystin-2 antibody. The same membrane was then stripped oﬀ and re-probed with the anti-rabbit IgG
antibody. Both control cells without transfection have no band with the same antibodies. Numbers at left are molecular masses (kDa). (B) Tran-
siently transfected NIH 3T3 and MDCK cells were co-stained with the anti-polycystin-2 and anti-rabbit IgG antibodies. One 3T3 and three MDCK
cells overexpressing TAP polycystin-2 showed complete image overlay (Merge). The surrounding non-overexpressing 3T3 cells serve as control and
display no signal for both antibodies, while the rest of MDCK cells display faint signals for the anti-polycystin-2 antibody, likely representing the
presence of endogenous polycystin-2. (C) MDCK stable cell line which survived in 800 lg/ml G418 for eight weeks was stained with the anti-
polycystin-2 antibody.
234 Q. Li et al. / FEBS Letters 576 (2004) 231–236
Fig. 5. Polycytin-2 channel activities in reconstituted planar lipid bi-
layer system. Functional assessment of the TAP-puriﬁed polycystin-2
was conducted in a lipid bilayer system. Single channel activity was
obtained under asymmetrical (A, 150 K/15 K) and symmetrical (B, 150
K/150 K) conditions. (A) Shown are representative traces of single-
channel currents recorded at +20 and )120 mV. The cis compartment
contained 150 mM KCl and 15 lM CaCl2 and the trans compartment
contained 15 mM KCl and 15 lM CaCl2. (B) representative traces at
+140 and )60 mV. Both compartments contained 150 mMKCl and 15
lM CaCl2. Signals were ﬁltered (Gaussian) at 200 Hz in Clampﬁt 9
(Axon Instruments). The close state is indicated by horizontal lines.
Fig. 4. Tandem aﬃnity puriﬁcation of polycystin-2 channel protein
from MDCK cells. A portion of proteins in each stage of puriﬁcation
was separated using 8% SDS–PAGE and visualized by silver staining
(A) and Western blotting probed with the anti-polycystin-2 antibody
(B). Lane 1, total cell lysate prior to fractionation; lane 2, enriched
protein complexes after incubation with protein A beads; lane 3,
protein eluates after incubation with TEV protease; lane 4, proteins
eluted from the calmodulin beads in the presence of 25 mM EGTA.
Samples were mixed with 4· sample buﬀer, denatured at 80 C for 5
min, then 20 ll (lanes 1 and 2) or 40 ll (lanes 3 and 4) was loaded.
Arrows indicate position of the fused polycystin-2 protein. Numbers at
left are molecular masses (kDa).
Q. Li et al. / FEBS Letters 576 (2004) 231–236 235mammalian cells using this two-step tandem puriﬁcation
procedure.
3.3. Characterization of polycystin-2 channel reconstituted in
lipid bilayer
To determine whether puriﬁed polycystin-2 protein pre-
serves its cation channel activity, we reconstituted it into pla-
nar lipid bilayers and performed electrophysiological
measurements. Experiments were conducted under symmetri-
cal (150 mM KCl in both the cis and trans chambers) and
asymmetrical (150 mM KCl in the cis chamber and 15 mM
KCl in the trans chamber) solution conditions. Spontaneous
channel activity was observed at both positive and negative
membrane potentials under asymmetrical and symmetrical
conditions (Fig. 5), demonstrating that puriﬁed polycystin-2
protein by our modiﬁed TAP protocol possesses the essential
characteristics normally present under physiological condi-
tions, e.g., those of endogenous or overexpressed polycystin-2
in mammalian cells. The main unitary conductance averaged
122 19 pS (N ¼ 6) under the symmetrical condition, which is
similar to the previously reported value of 134 pS using in vitro
translated polycystin-2 [16]. Under the asymmetrical condi-
tion, our data were ﬁtted with the GHK equation, whichyielded a main unitary conductance of 242 31 pS, which is
larger than the previously reported value of 177 pS [16], pos-
sibly due in part to the diﬀerent voltage ranges used ()140 to
+20 mV in the current experiments vs. )70 to +70 mV in [16]).
The MOT values were rather independent of the membrane
potential but were variable, ranging from few milliseconds to
hundreds of milliseconds. MOT averaged 125 33 ms
(N ¼ 19) and 128 58 ms (N ¼ 11), from data recorded at
voltages ranging from )120 to +120 mV, under symmetrical
and asymmetrical conditions, respectively. The MCT values
were relatively less variable and averaged 40 10 ms (N ¼ 25)
and 33 7 ms (N ¼ 18), respectively. Thus, there was no sig-
niﬁcant diﬀerence in the MOT and MCT values between the
symmetrical and asymmetrical conditions.4. Conclusion
The data presented in this study demonstrated the feasibility
of puriﬁcation of a membrane protein, polycystin-2 channel,
from cultured mammalian cells. Our modiﬁed TAP system in-
deed yielded proteins capable of correct assembly in reconsti-
tuted planar lipid bilayer to form functional cation channels.
This provides an alternative and eﬃcient avenue to study the
function of membrane proteins, such as ion channels, trans-
porters and receptors, as they are often expressed at low
abundance and/or sometimes in intracellular membranes (dif-
ﬁcult for electrophysiological studies). So far, in vitro transla-
tion and protein puriﬁcation from bacterium, yeast and insect
are common approaches for preparing membrane proteins but
they may produce proteins that are diﬀerent from their physi-
ological forms in mammalian cells, e.g., due to post-transla-
tional modiﬁcations. Although a reconstituted lipid bilayer is
an artiﬁcial system, it forms a pure system for studying ion
channels, which can be advantageous over a living cell. For
236 Q. Li et al. / FEBS Letters 576 (2004) 231–236example, hetero-complexing of polycystin-2 with other chan-
nels, such as TRPC1 [21], is a puzzling problem for discerning
channel signals in living cells. Thus, our modiﬁed TAP method
is not only applicable to identiﬁcation and analysis of novel
protein–protein interactions and protein complexes [8,9] but
also, together with lipid bilayer electrophysiology, provides an
adequate approach to study the function of an ion channel and
its functional modulation by a protein partner.
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